Atlas Trials

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis

Clinical trial NCT01231464 · COMPLETED

Trial details

NCT number
NCT01231464
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Rhinitis, Allergic, PerennialAllergic Rhinitis
Start date
2009-09-01
Primary completion
2010-05-01
Enrollment
365

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.